Experimental melanoma vaccine shows promising results
An experimental melanoma vaccine could reduce the risk of the cancer returning or spreading for some high-risk patients.
It's personalized for each patient and optimized using artificial intelligence.
Dr.
Jon LaPook has more details.
5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on www.cbsnews.com — the content belongs to CBS News Health.